Timing note: Allegion is scheduled to report today, Thursday, July 23, 2026, before the market opens, with its earnings call at 8:00 a.m. ET—not tomorrow. (investor.allegion.com)
Allegion enters Q2 with its full-year framework intact but with a meaningful burden of proof following a mixed first quarter. Q1 reported revenue rose 9.7%, though organic growth was only 2.6%, driven entirely by pricing more than offsetting a 2.0% volume decline. Adjusted EPS declined 3.2% to $1.80, and adjusted operating margin fell 150 bps to 21.2%. (investor.allegion.com)
The central question for investors is not simply whether ALLE delivers a Q2 beat versus the prior-year base. It is whether results validate management’s claims that:
Management reaffirmed FY2026 organic revenue growth of 2%–4% and adjusted EPS of $8.70–$8.90 after Q1, while lifting reported revenue growth guidance to 6%–8% to include the DCI acquisition. (investor.allegion.com)
| Q2 2025 actual | Result |
|---|---|
| Revenue | $1.022 billion |
| Organic revenue growth | 3.2% |
| Adjusted EPS | $2.04 |
| Adjusted operating margin | 23.7% |
| Americas organic growth / adjusted margin | 4.5% / 29.9% |
| International organic growth / adjusted margin | (2.2%) / 13.1% |
Q2 2025 featured high-single-digit Americas non-residential growth, volume growth plus price realization, and a notably strong Americas margin outcome. That makes the year-over-year margin comparison particularly difficult even if Q2 2026 improves sequentially from Q1. (investor.allegion.com)
In Q1, Americas organic growth was 4.5%, with price realization of 5.5% offset by a 1.0% volume decline. Non-residential grew mid-single digits organically, while residential was flat: pricing offset soft residential volumes. (investor.allegion.com)
For Q2, investors should focus on:
A price-led result that preserves organic growth may be sufficient to maintain guidance, but positive non-residential volume would be the cleaner signal that the growth outlook has upside.
Q1 margin pressure came from lower volumes, unfavorable mix, acquisitions, and the arithmetic effect of positive dollar pricing/productivity on the margin rate. Americas adjusted margin fell 110 bps to 28.1%, while International fell 220 bps to 8.0%. (investor.allegion.com)
Management previously indicated that Q2 Americas margins should improve from Q1 but may not show much year-over-year expansion; it also suggested International margin performance could remain softer year over year in Q2. Accordingly, a modest Q2 consolidated margin result should not, by itself, invalidate the FY outlook. The more important issue will be management’s confidence in a clearer second-half margin inflection.
International organic revenue declined 5.3% in Q1, largely because an ERP implementation disrupted production at a legacy European mechanical business. Management said the issue represented an operational—not demand—problem, with existing orders and backlog supporting recovery over the rest of 2026. (investor.allegion.com)
Q2 needs to show evidence that this recovery is real:
A limited recovery may still be acceptable if management can substantiate a second-half catch-up. Conversely, a further International shortfall would raise the risk that the FY EPS range requires an increasingly back-end-loaded recovery.
At Q1, Allegion estimated that recent tariff changes and other inflation would create an incremental headwind of roughly 1% of cost of goods sold. Management expected to offset this at adjusted operating income and EPS through a combination of pricing and cost actions, but had not incorporated incremental price into the organic-growth outlook because of the volatile environment. (investor.allegion.com)
The call should clarify:
The favorable outcome is an unchanged or improved EPS outlook with no worsening commentary on price/cost timing.
The DCI acquisition increases Allegion’s West Coast hollow-metal doors and frames capability and supports its non-residential package offering. However, DCI is initially lower margin and management indicated it would be a headwind to consolidated margin rate while being only modestly EPS accretive in 2026. (investor.allegion.com)
Capital allocation remains a secondary positive: Allegion repurchased roughly $40 million of stock in Q1, paid approximately $47 million of dividends, and received authorization for a new $500 million repurchase program. (investor.allegion.com)
A constructive Q2 would likely include:
The principal downside risks are:
ALLE’s Q2 report is primarily a test of execution against an already-reaffirmed full-year plan. The most important datapoints will be the quality of Americas demand, International ERP recovery, sequential margin progression, and the credibility of the second-half setup.
A modest quarter with maintained guidance can work if management demonstrates that the ERP disruption is behind it and that margin expansion is becoming visible. A weak International performance or further volume-driven margin pressure, however, would make the full-year EPS range more difficult to underwrite.